AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of AdvisorsMorningStar·23 hours agoSNY+1.58%
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline UpdatesMarket Beat·1 day ago, 12:01 AMRXRX-1.58%SNY+1.58%
MacroGenics Q2 FY26 turns to net income of $19.52 million; revenue more than doubled to $32.83 millionPUBT·Aug 13 at 03:14 PMMGNX-3.79%SNY+1.58%
Sanofi: Information concerning the total number of voting rights and shares - July 2026Unusual Whales·Aug 13 at 11:36 AMSNY+1.58%
Latigo Biotherapeutics files initial beneficial ownership statement for SanofiPUBT·Aug 12 at 07:10 AMLTGO-0.97%SNY+1.58%
Adagene FY26 H1 net loss widens to US$ 16.4 million; revenue turns to US$ 1.6 millionPUBT·Aug 12 at 06:38 AMADAG+3.51%SNY+1.58%
Regeneron posts transcript of Q2 2026 earnings conference callPUBT·Aug 6 at 01:48 PMREGN+0.30%SNY+1.58%
Novavax Q2 FY26 turns to net loss of $53.39 million; revenue drops 76.29% to $56.7 millionPUBT·Aug 6 at 06:54 AMNVAX+0.25%SNY+1.58%
Key facts: Kymera (KYMR) Q2 $65M; $1.5B cash; KT-621 data end-2026TradingView·Aug 6 at 02:15 AMKYMR+3.42%SNY+1.58%
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 4,356 Shares of StockMarket Beat·Aug 5 at 06:23 PMNRIX+0.44%SNY+1.58%
Kymera Q2 2026 Earnings: Milestone Revenue Narrows Net LossTradingKey·Aug 5 at 06:45 AMKYMR+3.42%GILD+0.40%
Why Investors Should Look at L3Harris, Cenovus, and SanofiBaystreet·Aug 5 at 03:41 AMSNY+1.58%CVE+3.61%
